Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Addex Therapeutics (ADXN) EBT Margin (2019 - 2025)

Addex Therapeutics' EBT Margin history spans 7 years, with the latest figure at 739347.58% for Q4 2025.

  • On a quarterly basis, EBT Margin fell 66044632.0% to 739347.58% in Q4 2025 year-over-year; TTM through Dec 2025 was 8161.71%, a 694595.0% decrease, with the full-year FY2025 number at 22829.93%, down 2161506.0% from a year prior.
  • EBT Margin came in at 739347.58% for Q4 2025, down from 5306.25% in the prior quarter.
  • The five-year high for EBT Margin was 1071.63% in Q4 2022, with the low at 739347.58% in Q4 2025.
  • Historically, EBT Margin has averaged 46537.96% across 5 years, with a median of 794.25% in 2022.
  • Biggest five-year swings in EBT Margin: skyrocketed 1162409bps in 2021 and later plummeted -66044632bps in 2025.
  • Year by year, EBT Margin stood at 1112.98% in 2021, then surged by 196bps to 1071.63% in 2022, then plummeted by -155bps to 585.21% in 2023, then crashed by -13383bps to 78901.26% in 2024, then tumbled by -837bps to 739347.58% in 2025.
  • Business Quant data shows EBT Margin for ADXN at 739347.58% in Q4 2025, 5306.25% in Q3 2025, and 78901.26% in Q4 2024.